Periodontitis can disrupt oral and gut microbiota, leading to dysbiosis that affects overall systemic health. Besides the spread of periodontal pathogens by the hematogenous route, they can also be translocated into the gastrointestinal tract, possibly intervening in the neoplastic process in the gastrointestinal tract. This manuscript reviews the relationship between oral and gut microbiota due to periodontitis, discussing systemic health implications and potential links to gastrointestinal cancer. This article highlights the significance and effect of dysbiosis in the gut, emphasizing the importance of maintaining oral health to prevent systemic diseases. Lastly, it will go through therapeutic innovations such as probiotics and oral microbiota analysis tools for systemic disease detection. These findings will mark the integration of oral health management in clinical practice to lower systemic disease risk and improve overall patient outcomes. Aim of work: This manuscript aims to unravel the pathological interaction between oral and gut microbiota and their bidirectional effect on systemic diseases. Materials and methods: The review was performed using the MEDLINE and ScienceDirect databases. Reviewed articles were published in English between the year 2015 and 2024. The search used keywords such as (“oral microbiota” AND “periodontal disease”) OR (“oral microbiota” AND “gastrointestinal cancer”) OR (“Porphyromonas gingivalis” AND “periodontal disease”) OR (“Helicobacter pylori” AND “gastric cancer”) OR (“gut microbiome” AND “inflammatory bowel disease”) OR (“oral microbiome” AND “systemic diseases”). Conclusions: The dysbiotic change in the oral cavity due to periodontitis is linked directly and indirectly to systemic diseases such as IBS, neurodegenerative diseases, muscle joint diseases, respiratory infections, and gastrointestinal cancer; this underscores the importance of maintaining oral hygiene for prophylaxis of oral diseases and the prevention of systemic diseases. A better understanding of the interconnections between oral health and systemic diseases will integrate oral health management to offer new prevention, diagnostic, and treatment opportunities to improve overall patient outcomes.

Bacterial resistance to antibiotics and the disruption of beneficial microbiota are key problems in contemporary medicine and make the search for new, more efficient infection treatment strategies among the most important tasks in medicine. Multicomponent plant-derived preparations with mild antibacterial activity created by many simultaneous mechanisms together with anti-inflammatory, innate immune and regenerative capacity-stimulating properties are good candidates for this therapy, and proanthocyanidins are among the most promising compounds of this sort. In this study, we have isolated proanthocyanidins from Pelargonium sidoides DC root extract and characterized and compared the composition, antioxidant properties and antibacterial activity of the proanthocyanidin fraction with those of the whole extract. The results revealed that proanthocyanidins had significantly stronger antioxidant capacity compared to the root extract and exhibited a unique antibacterial action profile that selectively targets Gram-negative keystone periodontal and peri-implant pathogenic strains, such as Porphyromonas gingivalis, while preserving the viability of beneficial oral commensal Streptococcus salivarius. The finding suggests that proanthocyanidins from Pelargonium sidoides root extract are good candidates for the prolonged and harmless treatment of infectious diseases.

In recent years, increasing attention has been given to adjunctive therapies aimed at improving clinical outcomes in periodontal treatment. Among these, antimicrobial photodynamic therapy (aPDT) using the photosensitizer indocyanine green (ICG) has shown great promise. Objective: This narrative review seeks to summarize the existing evidence from randomized controlled trials, systematic reviews, and in vitro and in vivo studies on the use of antimicrobial photodynamic therapy with indocyanine green (ICG) as a photosensitizer, as well as the emerging approach of double-light aPDT with ICG, in the treatment of periodontitis. Materials and Methods: PubMed, Web of Science, and Cochrane Library databases were searched to find relevant articles regarding the topic. The articles were published in English between the years 2015 and 2025. The search used keywords such as (“indocyanine green” AND “antimicrobial photodynamic therapy” AND (“efficiency” OR “efficacy” OR “effect”) AND (“periodont*” OR “gingivitis” OR “gingival” OR “gum”). The articles chosen were required to evaluate the treatment outcomes of periodontitis with ICG-aPDT. Conclusions: ICG-aPDT represents an effective adjunct treatment in periodontal therapy. It can non-invasively target biofilms and minimize systemic action. It makes this technique an attractive adjunct in modern periodontology practice. This narrative review shows that ICG-aPDT can be integrated into comprehensive periodontal care as an adjunct measure promoting tissue healing. However, more high-quality clinical trials are needed to develop standardized protocols and demonstrate long-lasting benefits.